|4Feb 27, 7:13 PM ET

Brennan Daniel J. 4

4 · WATERS CORP /DE/ · Filed Feb 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Waters (WAT) Director Daniel Brennan Receives Restricted Shares & Options

What Happened
Daniel J. Brennan, a director of Waters Corporation (WAT), was granted 23 restricted shares of common stock and a derivative award covering 57 shares on February 25, 2026. Both acquisitions are reported at $0.00 (no cash paid). The 23 shares are restricted stock; the 57-share item is an option/derivative award (not an exercise).

Key Details

  • Transaction date: February 25, 2026; Form 4 filed February 27, 2026 (filed within the typical two-business-day reporting window).
  • Grants: 23 restricted shares at $0.00 (total $0) and a 57-share derivative/option award at $0.00 (total $0).
  • Shares owned after transaction: not specified in the provided excerpt.
  • Footnotes: F1 — the 23 restricted shares vest 100% on February 9, 2027. F2 — the 57-share option will vest and become exercisable on February 9, 2027.
  • Transaction code: A = Award/Grant (acquisition). No 10b5-1 plan, tax-withholding, or sale reported in the excerpt.

Context
This filing reports director compensation (restricted stock and an option grant), not an option exercise or open-market trade. Restricted shares and director option grants are common components of board compensation and do not by themselves indicate immediate buying/selling intent. The option grant creates the right to acquire shares in the future once it vests; it is not an immediate purchase or sale.

Insider Transaction Report

Form 4
Period: 2026-02-25
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-25+231,355 total
  • Award

    Stock Option (Right to Buy)

    [F2]
    2026-02-25+5757 total
    Exercise: $319.44From: 2027-02-09Exp: 2036-02-25Common Stock (57 underlying)
Footnotes (2)
  • [F1]Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.
  • [F2]All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.
Signature
/s/ Michael Lynn, attorney-in-fact for Daniel Brennan|2026-02-27

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT